This statistic shows the comparison of the share of hepatitis B therapeutic sales among eight major markets in 2014 and 2024. China's share among the global eight major markets for chronic hepatitis B therapeutics was some 39 percent in 2014, and it is predicted to increase to over 47 percent in 2024.
Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024
All data is based on primary research interviews and surveys
conducted with KOLs and high-prescribing physicians in the countries
included in this report.
* Forecast
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
GlobalData. (January 1, 2016). Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024 [Graph]. In Statista. Retrieved November 13, 2024, from https://www.statista.com/statistics/648513/hepatitis-b-therapeutic-sales-share-within-major-markets/
GlobalData. "Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024." Chart. January 1, 2016. Statista. Accessed November 13, 2024. https://www.statista.com/statistics/648513/hepatitis-b-therapeutic-sales-share-within-major-markets/
GlobalData. (2016). Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024. Statista. Statista Inc.. Accessed: November 13, 2024. https://www.statista.com/statistics/648513/hepatitis-b-therapeutic-sales-share-within-major-markets/
GlobalData. "Share of Chronic Hepatitis B Therapeutic Sales among 8 Major Markets in 2014 and 2024." Statista, Statista Inc., 1 Jan 2016, https://www.statista.com/statistics/648513/hepatitis-b-therapeutic-sales-share-within-major-markets/
GlobalData, Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024 Statista, https://www.statista.com/statistics/648513/hepatitis-b-therapeutic-sales-share-within-major-markets/ (last visited November 13, 2024)
Share of chronic hepatitis B therapeutic sales among 8 major markets in 2014 and 2024 [Graph], GlobalData, January 1, 2016. [Online]. Available: https://www.statista.com/statistics/648513/hepatitis-b-therapeutic-sales-share-within-major-markets/